Compare NYXH & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NYXH | EARN |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.1M | 200.3M |
| IPO Year | 2021 | 2013 |
| Metric | NYXH | EARN |
|---|---|---|
| Price | $5.01 | $5.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.67 | $5.88 |
| AVG Volume (30 Days) | 35.2K | ★ 321.3K |
| Earning Date | 11-13-2025 | 02-20-2026 |
| Dividend Yield | N/A | ★ 18.01% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,616,215.00 | ★ $35,893,000.00 |
| Revenue This Year | $75.27 | $8.43 |
| Revenue Next Year | $277.15 | $17.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 10.96 | ★ 43.30 |
| 52 Week Low | $4.35 | $4.33 |
| 52 Week High | $11.87 | $6.82 |
| Indicator | NYXH | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 59.59 |
| Support Level | $4.45 | $5.23 |
| Resistance Level | $4.86 | $5.39 |
| Average True Range (ATR) | 0.23 | 0.10 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 90.69 | 88.05 |
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.